DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it has entered...
Bioventus Announces Inducement Equity to President and CEO Robert Claypoole
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (œBioventus or the œCompany), a global leader in innovations for active healing, today announced that its Board of...
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (œBioventus or the œCompany), a global leader in innovations for active healing, has agreed to a nationwide contract...
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...